Skip to Main Content

Vaxart, Inc Common Stock

VXRT Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
VXRT Income Statement
VXRT Balance Sheet
VXRT Cash Flow

Recent trades of VXRT by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
VXRT Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
VXRT Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
VXRT Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by VXRT's directors and management

Government lobbying spending instances

  • $20,000 Jan 18, 2023 Issue: Health Issues
  • $80,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Oct 20, 2022 Issue: Health Issues
  • $80,000 Oct 17, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jul 20, 2022 Issue: Health Issues
  • $80,000 Jul 18, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $80,000 Apr 19, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Apr 18, 2022 Issue: Health Issues
  • $80,000 Jan 20, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jan 18, 2022 Issue: Health Issues
  • $20,000 Oct 23, 2021 Issue: Health Issues
  • $80,000 Oct 20, 2021 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jul 22, 2021 Issue: Health Issues
  • $80,000 Jul 20, 2021 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Apr 20, 2021 Issue: Health Issues
  • $80,000 Apr 20, 2021 Issue: Medical/Disease Research/Clinical Labs
  • $50,000 Jan 21, 2021 Issue: Medical/Disease Research/Clinical Labs
  • $20,000 Jan 20, 2021 Issue: Health Issues
  • $20,000 Oct 20, 2020 Issue: Health Issues

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Formulations for small intestinal delivery of rsv and norovirus antigens Sep. 06, 2022
  • Patent Title: Piperidine derivatives as human papilloma virus inhibitors May. 22, 2018
  • Patent Title: Chimeric adenoviral vectors Apr. 07, 2015
  • Patent Title: Chimeric adenoviral vectors Jul. 17, 2012
  • Patent Title: Chimeric adenoviral vectors Feb. 01, 2011
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of VXRT in WallStreetBets Daily Discussion

VXRT News

Recent insights relating to VXRT

CNBC Recommendations

Recent picks made for VXRT stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in VXRT

VXRT Top Shareholders
Shareholder
Shares Held
VXRT Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

VXRT Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view VXRT Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top